Rapidly progressive skin & soft tissue infections
[Clin Infect Dis 2014;59:e10-52]
Predisposing factors
trauma/surgery
immunosuppression/malignancy
diabetes
chronic renal/hepatic disease
chicken pox
IVDU
Clinical Findings
Early:
pain out of proportion to appearance
edema or tenderness beyond the cutaneous erythema
cellulitis
fever
tachycardia
induration (hard, wooden feel of subcutaneous tissue)
areas of anaesthesia in affected skin
Late:
severe pain
skin discoloration/necrosis (purple or black)
blistering
hemorrhagic bullae
crepitus
"dishwater" gray drainage
systemic inflammatory response syndrome (SIRS)/sepsis
multi-organ failure/shock
Management
- Surgical debridement and irrigation are essential. Send specimens for culture. For culture-directed therapy, see Culture-Directed Infections: Skin & Soft Tissue.
- Infectious Diseases consult strongly recommended.
- Duration of therapy (IV/PO) dependent on clinical picture.
Rapidly progressive skin & soft tissue infections
- On initial presentation it may be difficult to determine etiologic agent(s).
S. pyogenes (Group A Strep)
Mixed aerobic/anaerobic organisms
S. agalactiae (Group B Strep)
Group C,G Strep
S. pneumoniae
S. aureus/MRSA
Clostridium spp
Vibrio vulnificus (salt water exposure)
Aeromonas hydrophila (fresh water exposure)
Enterobacterales (chronic hepatic/renal disease)
P. aeruginosa (neutropenia, burns, IVDU)
Empiric Therapy | Dose | Duration |
---|---|---|
Ceftriaxone | 2g IV daily | 10-14 days |
+ | ||
Clindamycin | 600-900mg IV q8h |
Polymicrobial or MRSA suspected
Empiric Therapy | Dose | Duration |
---|---|---|
Piperacillin-tazobactam | 4.5g IV q6h | 10-14 days |
+ | ||
[Vancomycin | 15mg/kg IV q12h | |
or | ||
Linezolid] | 600mg IV/PO q12h |
Penicillin allergy
Empiric Therapy | Dose | Duration |
---|---|---|
Imipenem | 500mg IV q6h | 10-14 days |
+ | ||
[Vancomycin | 15mg/kg IV q12h | |
or | ||
Linezolid] | 600mg IV/PO q12h |